Usana Health Sciences (USNA) Non-Current Deferred Tax Liability (2016 - 2026)
Usana Health Sciences has reported Non-Current Deferred Tax Liability over the past 16 years, most recently at $5.1 million for Q2 2026.
- Quarterly Non-Current Deferred Tax Liability rose 5.33% to $5.1 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Apr 2026, up 5.33% year-over-year, with the annual reading at $4.9 million for FY2026, 20.11% up from the prior year.
- Non-Current Deferred Tax Liability was $5.1 million for Q2 2026 at Usana Health Sciences, up from $4.9 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $32.5 million in Q4 2022 and troughed at $4.1 million in Q4 2024.
- The 5-year median for Non-Current Deferred Tax Liability is $4.8 million (2022), against an average of $6.9 million.
- Year-over-year, Non-Current Deferred Tax Liability surged 333.92% in 2022 and then plummeted 86.01% in 2023.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $32.5 million in 2022, then plummeted by 86.01% to $4.6 million in 2023, then dropped by 10.52% to $4.1 million in 2024, then increased by 9.67% to $4.5 million in 2025, then rose by 13.21% to $5.1 million in 2026.
- Per Business Quant, the three most recent readings for USNA's Non-Current Deferred Tax Liability are $5.1 million (Q2 2026), $4.9 million (Q1 2026), and $4.5 million (Q3 2025).